Rituximab Compared with Azathioprine as Maintenance Therapy in Relapsing ANCA-Associated Vasculitis: RITAZAREM

Study Findings: This study demonstrated that patients with ANCA-associated vasculitis, with a prior history of relapse, who receive maintenance therapy with rituximab are more likely to remain in remission than those given azathioprine. View Publication.

ClinicalTrials.gov ID: NCT01697267

Study Dates: 2012-2020

Disease(s): Granulomatosis with Polyangiitis (GPA)